Literature DB >> 7409860

Activated macrophages pre-incubated in vitro enhance rather than suppress mitogen-stimulated lymphocyte transformation.

E J Wing, J S Remington.   

Abstract

It has previously been shown in mice that activated peritoneal macrophages, when first removed from the peritoneal cavity, suppress mitogen-stimulated lymphocyte transformation in vitro as measured by [3H]-thymidine incorporation. In this study, it is demonstrated that activated macrophages that have been incubated alone in vitro (pre-incubated) for greater than 8--12 h, lose the capacity to suppress and in fact markedly enhance mitogen-stimulated lymphocyte transformation. This enhancement of lymphocyte transformation by activated macrophages occurred over a wide range of macrophage concentrations and required viable macrophages. Supernatants collected from pre-incubated activated macrophages did not enhance lymphocyte transformation. Paradoxically, pre-incubated activated macrophages did not lose the capacity to inhibit multiplication of intracellular Toxoplasma gondii. Thus, one, but not necessarily all functional capacities of activated macrophages, is markedly altered by in vitro incubation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7409860      PMCID: PMC1457987     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Major changes in lymphocyte proliferation evoked by activated macrophages.

Authors:  R Keller
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

2.  Mechanisms of action of "lymphocyte-activating factor" (LAF). III. Evidence that LAF acts on stimulated lymphocytes by raising cyclic GMP in G1.

Authors:  S P Katz; F Kierszenbaum; B H Waksman
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

3.  Macrophage heterogeneity in receptor activity: the activation of macrophage Fc receptor function in vivo and in vitro.

Authors:  J Rhodes
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

4.  Two biological activities regulating cell proliferation found in cultures of peritoneal exudate cells.

Authors:  J Calderon; E R Unanue
Journal:  Nature       Date:  1975-01-31       Impact factor: 49.962

5.  In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with Corynebacterium parvum.

Authors:  M Olivotto; R Bomford
Journal:  Int J Cancer       Date:  1974-04-15       Impact factor: 7.396

6.  A role for activated macrophages in resistance to infection with Toxoplasma.

Authors:  J S Remington; J L Krahenbuhl; J W Mendenhall
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

7.  Lymphocyte reactivity in vitro. I. Cellular reconstitution of purified lymphocyte response.

Authors:  B J Alter; F H Bach
Journal:  Cell Immunol       Date:  1970-07       Impact factor: 4.868

8.  Potentiation of cultured mouse thymocyte responses by factors released by peripheral leucocytes.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

9.  Synergistic interaction of macrophages and lymphocytes in antigen-induced transformation of lymphocytes.

Authors:  R C Seeger; J J Oppenheim
Journal:  J Exp Med       Date:  1970-07-01       Impact factor: 14.307

10.  Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum.

Authors:  A Ghaffar; R T Cullen; N Dunbar; M F Woodruff
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

View more
  3 in total

1.  The effect of human monocytes and macrophages on lymphocyte proliferation.

Authors:  J H Passwell; M Levanon; J Davidsohn; F Kohen; B Ramot
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

2.  Bacillus Calmette-Guérin (BCG) decreases resistance to Listeria monocytogenes infection in mice.

Authors:  E J Wing
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

3.  Human bronchoalveolar macrophage cytotoxicity for cultured human lung-tumour cells.

Authors:  S Swinburne; M Moore; P Cole
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.